RIG
BIIB icon

Renaissance Investment Group’s Biogen BIIB Stock Holding History

Renaissance Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-940
Closed -$332K – 76
2018
Q3 		$332K Hold
940
– – 0.13% 71
2018
Q2 		$273K Hold
940
– – 0.11% 75
2018
Q1 		$257K Hold
940
– – 0.1% 72
2017
Q4 		$299K Hold
940
– – 0.12% 72
2017
Q3 		$294K Hold
940
– – 0.12% 69
2017
Q2 		$255K Hold
940
– – 0.11% 75
2017
Q1 		$257K Buy
+940
New +$266K 0.11% 75

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Investment Group's BIIB Position: Q4 2018 in Review

Renaissance Investment Group sold out of Biogen (BIIB) in Q4 2018, closing a stake of 940 shares — an estimated $332K sold.

Renaissance Investment Group first reported a position in BIIB in Q1 2017 and held it in 7 quarters. The position peaked at $332K in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Renaissance Investment Group reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Renaissance Investment Group sold 940 Biogen shares in Q4 2018, an estimated $332K.
  • Renaissance Investment Group first reported a position in Biogen in Q1 2017 and held it in 7 quarters.
  • Renaissance Investment Group's Biogen position peaked at $332K in Q3 2018.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Renaissance Investment Group's 13F filing for Q4 2018, filed 25 Jan 2019.